Abiopharma

🔍 Klein Jason (Executive)

Company: Paymentus Holdings, Inc. (PAY)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Acquired 950 shares of Class A Common Stock (Direct)
  Date: 2026-08-17 | Code: J | equity_swap_involved: false | shares_owned_after: 950.00 | transaction_form_type: 5 | Footnotes: F1, F1, F2
• Acquired 328,915 shares of Class B Common Stock (Derivative)
  Date: 2026-08-17 | Code: J | equity_swap_involved: false | shares_owned_after: 2,499,918.00 | transaction_form_type: 5 | Footnotes: F3, F1, F1, F3, F3, F2

Footnotes:

• F1: Shares received in a pro rata distribution from funds affiliated with Accel-KKR. The acquisition of such shares was exempt pursuant to Rule 16a-9(a) under the Securities Exchange Act of 1934, as amended.
• F2: Shares held by The Jason and Farah Klein Revocable Trust dtd 1/27/2011.
• F3: Class B Common Stock is convertible at any time, at the holder's election and automatically in connection with certain transfers and upon certain other events, into an equal number of shares of Class A Common Stock and has no expiration date.